153 related articles for article (PubMed ID: 38326905)
21. Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro.
Wen H; Li Z; Song S; Xu L; Tong X; Yan H
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):446-453. PubMed ID: 33637977
[TBL] [Abstract][Full Text] [Related]
22. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
23. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
Yang X; Zhang Y; Fan H
Cancer Gene Ther; 2021 Aug; 28(7-8):813-827. PubMed ID: 32719443
[TBL] [Abstract][Full Text] [Related]
25. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.
Gu H; Lin R; Zheng F; Zhang Q
J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720
[TBL] [Abstract][Full Text] [Related]
26. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
27. LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4.
Li J; Yuan X; Ma C; Li J; Qu G; Yu B; Cai F; Peng Y; Liu L; Zeng D; Jiao Q; Zhang J; Luo X; Liao Q; Lv XB
Front Oncol; 2023; 13():1139588. PubMed ID: 37035213
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression.
Zhao A; Wang Y; Lin F; Bai K; Gu C
J Biochem Mol Toxicol; 2022 May; 36(5):e23020. PubMed ID: 35253306
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
[TBL] [Abstract][Full Text] [Related]
30. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
[TBL] [Abstract][Full Text] [Related]
31. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
33. lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A.
Hu Z; Li L; Cheng P; Liu Q; Zheng X; Peng F; Zhang Q
J Cell Biochem; 2020 Oct; 121(10):4085-4093. PubMed ID: 31916281
[TBL] [Abstract][Full Text] [Related]
34. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA LINC00565 regulates
Meng B; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Yan C
Chin J Physiol; 2023; 66(6):474-484. PubMed ID: 38149560
[TBL] [Abstract][Full Text] [Related]
37. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of N6-Methylandenosine-Related lncRNAs in Clear Cell Renal Cell Carcinoma: A Correlation With Prognosis, Tumor Progression, and Therapeutic Response.
Meng C; Li J; Wang X; Ying Y; Li Z; Wang A; Li X
Cancer Invest; 2024 Apr; 42(4):278-296. PubMed ID: 38644691
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of long noncoding RNA PGM5-AS1 correlates with tumor progression and predicts poor prognosis in clear cell renal cell carcinoma.
Qian M; Zheng JL; Kang N; Su YL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10685-10690. PubMed ID: 31858536
[TBL] [Abstract][Full Text] [Related]
40. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
